Product NDC: | 0078-0442 |
Proprietary Name: | Ritalin |
Non Proprietary Name: | methylphenidate hydrochloride |
Active Ingredient(s): | 20 mg/1 & nbsp; methylphenidate hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0442 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018029 |
Marketing Category: | NDA |
Start Marketing Date: | 19820331 |
Package NDC: | 0078-0442-05 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0078-0442-05) |
NDC Code | 0078-0442-05 |
Proprietary Name | Ritalin |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0078-0442-05) |
Product NDC | 0078-0442 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylphenidate hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19820331 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |